CME (CME) financial statements
CME reported revenue of $6.5B in fiscal 2025, up 6.8% a year over 9 years.
Net income was $4.1B and the operating margin 64.9%, against 61.2% in 2016.
Free cash flow was $4.2B, and the company returned $3.9B in dividends.
The diluted share count rose 6% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from CME's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.6B | $4.3B | $4.9B | $4.9B | $4.7B | $5.0B | $5.6B | $6.1B | $6.5B |
| Operating income | $2.2B | $2.3B | $2.6B | $2.6B | $2.6B | $2.6B | $3.0B | $3.4B | $3.9B | $4.2B |
| Interest expense | $124M | $117M | $158M | $178M | $166M | $167M | $163M | $159M | $161M | $173M |
| Pre-tax income | $2.3B | $2.5B | $2.8B | $2.7B | $2.7B | $3.4B | $3.5B | $4.2B | $4.5B | $5.3B |
| Income tax | $754M | -$1.5B | $814M | $574M | $616M | $737M | $799M | $927M | $1.0B | $1.3B |
| Net income | $1.5B | $4.1B | $2.0B | $2.1B | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | $4.1B |
| EPS (diluted) | $4.53 | $11.94 | $5.71 | $5.91 | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 |
| Diluted shares | 339M | 340M | 344M | 358M | 359M | 359M | 359M | 360M | 360M | 360M |
| Operating margin | 61.2% | 63.4% | 60.5% | 53.2% | 54.0% | 56.4% | 60.1% | 61.6% | 64.1% | 64.9% |
| Net margin | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% |
Balance sheet
Fiscal years, from CME's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $2.0B | $2.0B | $1.4B | $1.6B | $1.7B | $2.9B | $2.8B | $3.0B | $3.0B | $4.5B |
| Receivables | $364M | $360M | $553M | $492M | $461M | $434M | $483M | $536M | $573M | $639M |
| Total current assets | $40.0B | $46.9B | $41.9B | $39.6B | $89.3B | $161.8B | $139.1B | $94.9B | $103.0B | $165.4B |
| Property, plant and equipment | $425M | $400M | $449M | $544M | $579M | $505M | $456M | $410M | $386M | $363M |
| Goodwill | $7.6B | $7.6B | $10.8B | $10.7B | $10.8B | $10.5B | $10.5B | $10.5B | $10.5B | $10.5B |
| Total assets | $69.4B | $75.8B | $77.5B | $75.2B | $124.7B | $196.8B | $174.2B | $129.7B | $137.4B | $198.4B |
| Total current liabilities | $38.9B | $45.7B | $41.3B | $38.5B | $88.2B | $160.4B | $137.7B | $93.4B | $102.3B | $160.3B |
| Total liabilities | $49.0B | $53.4B | $51.5B | $49.1B | $98.3B | $169.4B | $147.3B | $103.0B | $111.0B | $169.7B |
| Shareholders' equity | $20.3B | $22.4B | $26.0B | $26.2B | $26.4B | $27.4B | $26.9B | $26.7B | $26.5B | $28.7B |
| Net debt | -$1.9B | -$1.9B | -$1.4B | -$1.6B | -$1.6B | -$2.8B | -$2.7B | -$2.9B | -$2.9B | -$4.4B |
Cash flow
Fiscal years, from CME's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.7B | $1.8B | $2.4B | $2.7B | $2.7B | $2.4B | $3.1B | $3.5B | $3.7B | $4.3B |
| Capital spending | $92M | $82M | $117M | $246M | $198M | $127M | $90M | $76M | $94M | $84M |
| Free cash flow | $1.6B | $1.7B | $2.3B | $2.4B | $2.5B | $2.3B | $3.0B | $3.4B | $3.6B | $4.2B |
| Stock-based compensation | $66M | $58M | $96M | $73M | $96M | $75M | $84M | $83M | $90M | $95M |
| Dividends paid | $1.8B | $2.0B | $2.1B | $1.7B | $2.1B | $2.2B | $2.6B | $3.2B | $3.6B | $3.9B |
| Net borrowing | $0 | $0 | $1.6B | -$92M | -$305M | $0 | $0 | — | — | — |
| Free cash flow margin | 45.6% | 45.8% | 53.9% | 49.9% | 51.6% | 48.5% | 59.1% | 60.5% | 58.7% | 64.3% |
| Dividends per share | $5.27 | $5.86 | $6.25 | $4.73 | $5.89 | $6.10 | $7.33 | $9.00 | $9.96 | $10.92 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CME.
Open CME in InvestinglyQuestions
What was CME's revenue in 2025?
$6.5B in fiscal 2025, from its 10-K filing.
How much free cash flow does CME generate?
$4.2B in fiscal 2025 (operating cash flow minus capital spending).
From CME's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.